Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis

Medicine and Dentistry

• Hepatocellular Carcinoma 100%
• Liver Cirrhosis 50%
• Patient 41%
• Development 33%
• Hazard Ratio 33%
• Inpatient 33%
• Antiviral Therapy 25%
• Enalapril Maleate 25%
• Polyacrylamide Gel Electrophoresis 16%
• Senescence 8%
• High Risk Population 8%
• Serum Albumin 8%
• Hepatitis B Virus 8%
• Proportional Hazards Model 8%
• Regression Analysis 8%
• Chronic Hepatitis B 8%
• Cumulative Incidence 8%
• Intermediate Risk Population 8%
• Low Platelet Count 8%
• Therapeutic Procedure 8%
• Assessment 8%
• Incidence 8%

Biochemistry, Genetics and Molecular Biology

• Development 33%
• Incidence 16%
• Hepatitis B Virus 8%
• Senescence 8%
• Platelet Count 8%
• Serum Albumin 8%
• Albumin Level 8%
• High Risk Population 8%
• Time 8%
• Intermediate Risk Population 8%
• Serial Analysis of Gene Expression 8%